Tissue Engineering Market - Size, Share, Trends, and Forecast, 2022 - 2028

Tissue Engineering Market - Size, Share, Trends, and Forecast, 2022 - 2028

Tissue engineering is a scientific field majorly focused on the development of tissue and organ substitutes by controlling biophysical, biological, and/or biomechanical parameters in the laboratory. Tissue engineering has emerged as a rapidly expanding approach to address shortage of organs in transplantation procedures and is a major component of regenerative medicine. The general principles of tissue engineering involve combining living cells with a synthetic or natural support or scaffold to build a three dimensional living construct that is structurally, functionally, and mechanically equal to or better than the tissue that is to be replaced.

Market Dynamics

Scientific advancements in the fields of cell and molecular biology, genetics, biochemistry, biomedical engineering and materials science have opened new growth opportunities in the field of tissue engineering. Rising need for effective regenerative treatments due to the rapidly aging population coupled with increasing population suffering from diseases such as cancer, diabetes, and obesity and growth in burn and trauma cases are expected to drive the tissue engineering market growth during the forecast period. According to the World Health Organization (WHO), global diabetic population is expected to reach 336 million by 2030, from 270 million in 2015.

However, tissue engineering processes used for development of complex tissues or organs, such as heart, is facing challenges such as dearth of cell sources, biomaterials, vascularization of engineered tissues, and design of drug delivery systems. Moreover, harvesting autografts is painful, expensive, constrained by anatomical limitations and donor-site morbidity due to hematoma and infection, which is hindering growth of the market.

Key features of the study:

This report provides in-depth analysis of the tissue engineering market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global tissue engineering market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global tissue engineering market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:

Global Tissue Engineering Market, By Material Type:
Synthetic
Biological
Others
Global Tissue Engineering Market, By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Global Tissue Engineering Market, By Region:
North America
By Country:
U.S.
Canada
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Company Profiles
Acelity L.P. Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Allergan Plc.
Athersys, Inc.
Braun
BioMimetic Therapeutics
Bio Tissue Technologies
R. Bard
International Stem Cell
Integra Lifesciences
Medtronic, Inc.
Organogenesis Inc.
Osiris Therapeutics
RTI surgical, Inc.
Stryker Corporation
Tissue Regenix Group Plc.
Zimmer Biomet
“*” marked represents similar segmentation in other categories in the respective section.